MK-0000-413

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0000-413, covering 2024-10-28 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413) [Phase 1]